Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Enteroshield Vaccine

Enteroshield Vaccine is a conjugate vaccine used for active immunization against typhoid fever. It contains the Vi capsular polysaccharide of Salmonella typhi conjugated to Tetanus toxoid, enhancing the immune response, especially in younger children. Administered parenterally, it helps provide long-lasting protection against typhoid.

In stock
SKU
SBEN02988
Price: 0.00 (Inclusive of Taxable Goods)
Enteroshield Vaccine is available to buy in increments of 1

Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Features:

  • Conjugate Vaccine: Provides enhanced and longer-lasting immunity by conjugating the antigen with a carrier protein (Tetanus toxoid).

  • Effective Against Typhoid: Specifically targets Salmonella typhi serovar Ty2.

  • Suitable for Children and Adults: Designed to be effective even in children below 2 years.

  • Single-Dose Protection: Often administered as a single injection for prolonged immunity.

  • Trusted Manufacturer: Produced by Abbott India Ltd, a reputed pharmaceutical company.

Technical Details
Technical Specification
  • Active Ingredients:

    • Vi Capsular Polysaccharide of Salmonella typhi Ty2 Conjugated to Tetanus Toxoid – 25 mcg

    • Sodium Chloride – 4.5 mg

  • Dosage Form: Injectable solution

  • Route of Administration: Parenteral (Intramuscular injection)

  • Pack Size: Single-dose prefilled syringe or vial (as per packaging)

  • Storage Conditions: 2°C to 8°C (Do not freeze)

  • Type: Prescription Drug

  • Manufacturer: Abbott India Ltd

  • Consume Type: Parenteral

  • Bottle of 0.5 ml
  • Long-Lasting Immunity: Offers durable protection against typhoid fever.

  • Early Immunization Possible: Safe and effective for infants above 6 months.

  • Improved Immune Response: Conjugate formulation ensures better immunogenicity than polysaccharide vaccines.

  • Globally Recognized Standard: Complies with WHO recommendations.

  • Reduced Carrier State: Helps lower the risk of typhoid transmission in communities.

Your Practice might also need
Copyright © 2023-present SignelbioMedical, Inc. All rights reserved.